Thalidomide, a drug capable of causing fetal abnormalities (teratogen), has caused greater than ten thousand birth defects worldwide since its introduction to the market as a pharmaceutical agent. Prior to discovering thalidomide's teratogenic effects in the early 1960s, the US Food and Drug Administration (FDA) did not place regulations on drug approval or monitoring as it later did. By 1962, approximately 20,000 patients in the US had taken thalidomide as part of an unregulated clinical trial before any actions were taken to stop thalidomide's distribution. Due to thalidomide's effects on fetuses, both nationally and abroad, the US Congress passed the 1962 Kefauver-Harris Amendments to the 1938 Food, Drug, and Cosmetic Act. These amendments imposed guidelines for the process of drug approval in the US and required that a drug be safe as well as effective before it could be approved and marketed. Thalidomide also influenced the FDA's creation of pregnancy categories; a ranking of drugs based on their effects on reproduction and pregnancy. Thalidomide motivated the laws on regulating and monitoring drugs developed in the US and by the FDA in the twentieth and twenty-first centuries.

Albert Ludwig Sigesmund Neisser was a physician and scientist working in Poland who, in 1879, identified the bacterium that causes gonorrhea. Before Neisser’s discovery, physicians and scientists were unsure of what causes gonorrhea, a sexually transmitted infection, or STI, that typically causes genital pain and discharge in those infected. Using newly available microscopy techniques, Neisser examined genital discharge from patients with gonorrhea and observed the bacteria that eventually became known as Neisseria gonorrhoeae, named in his honor. Beyond discovering the bacterial cause of gonorrhea, Neisser also directed a dermatology clinic in Breslau, Poland, and researched other diseases including syphilis and leprosy. In addition to his discoveries, he also experienced scandals and ethical controversies regarding his research practices, which resulted in the implementation of directives regarding informed consent. By identifying the causative agent of gonorrhea, Neisser enabled future physicians and scientists to develop treatments for a disease that can cause infertility and be passed from mother to child causing serious illness in infants.